News

Acquisition of Vortechs Group Inc. Assets and Total Voting Rights Update

Thursday, April 28th, 2016

28 April 2016 | The London Stock Exchange


Acquisition of Vortechs Group Inc. Assets and Total Voting Rights Update

Abstract: Tekcapital plc (AIM: TEK), an international provider of technology and intellectual property services, is pleased to announce the acquisition of the certain assets and the business of Vortechs Group Inc. (“Vortechs Group”), a leading technology transfer executive search firm.

Contact:

(UK) Walbrook PR Limited: Tel. +44 (0) 207 933 8780

About Tekcapital – The World’s Largest University Network for Open Innovation
Tekcapital helps clients profit from new, university-developed intellectual properties.
With our proprietary discovery search engine, linked to 4,000+ universities in 160 countries, coupled with expert scientific review, we provide a turn-key service to make it easy for clients to find and acquire the IP they need to create a competitive advantage.

Tekcapital considers AIM IPO of UK Medical Device Firm Belluscura

Wednesday, April 13th, 2016

13 April 2016 | LSE Alliance News

TEKCAPITAL CONSIDERS AIM IPO OF UK MEDICAL DEVICE FIRM BELLUSCURA (ALLIPO)

Abstract: LONDON (Alliance News) – Tekcapital PLC, the AIM-listed university technology and intellectual property services company, on Wednesday said it is considering an initial public offering of Belluscura Ltd, its newly formed UK subsidiary, which acquired exclusive licences to manufacture and sell three proprietary medical devices.

Contact:

(UK) Walbrook PR Limited: Tel. +44 (0) 207 933 8780

About Tekcapital – The World’s Largest University Network for Open Innovation
Tekcapital helps clients profit from new, university-developed intellectual properties.
With our proprietary discovery search engine, linked to 4,000+ universities in 160 countries, coupled with expert scientific review, we provide a turn-key service to make it easy for clients to find and acquire the IP they need to create a competitive advantage.

Acquisition of Medical Devices Establishment of Subsidiary Company to Provide Premium Medical Products at Affordable Prices

Wednesday, April 13th, 2016

13 April 2016 | London Stock Exchange

Acquisition of Medical Devices Establishment of Subsidiary Company to Provide Premium Medical Products at Affordable Prices

Abstract: Tekcapital plc (AIM: TEK), an international provider of technology and intellectual property services, announces that its subsidiary, Belluscura Limited, has acquired exclusive licences to manufacture and sell three proprietary medical devices. The devices have been developed by and exclusively licensed from Stryker Corporation, a leading medical technology company. The devices have achieved regulatory approval where necessary and have already achieved commercial sales.

Contact:

(UK) Walbrook PR Limited: Tel. +44 (0) 207 933 8780

About Tekcapital – The World’s Largest University Network for Open Innovation
Tekcapital helps clients profit from new, university-developed intellectual properties.
With our proprietary discovery search engine, linked to 4,000+ universities in 160 countries, coupled with expert scientific review, we provide a turn-key service to make it easy for clients to find and acquire the IP they need to create a competitive advantage.

End of blood tests in sight for diabetes as Tekcapital acquires patent for breakthrough glucose testing technology

Monday, March 14th, 2016

14 March 2016 | The Telegraph

End of blood tests in sight for diabetes as Tekcapital acquires patent for breakthrough glucose testing technology

Abstract: Aim-listed Tekcapital has acquired the exclusive license to a groundbreaking patent application for non-invasive glucose testing technology, which could overhaul the way diabetes sufferers monitor their blood sugar levels.

Contact:

(UK) Walbrook PR Limited: Tel. +44 (0) 207 933 8780

About Tekcapital – The World’s Largest University Network for Open Innovation
Tekcapital helps clients profit from new, university-developed intellectual properties.
With our proprietary discovery search engine, linked to 4,000+ universities in 160 countries, coupled with expert scientific review, we provide a turn-key service to make it easy for clients to find and acquire the IP they need to create a competitive advantage.

Diabetes: Tekcapital acquires patent for non-invasive glucose testing technology

Monday, March 14th, 2016

14 March 2016 | International Business Times

Diabetes: Tekcapital acquires patent for non-invasive glucose testing technology

Abstract: Tekcapital has acquired an exclusive patent for a technology dealing in non-invasive glucose testing. This could change the way people with diabetes test their blood sugar levels.

Contact:

(UK) Walbrook PR Limited: Tel. +44 (0) 207 933 8780

About Tekcapital – The World’s Largest University Network for Open Innovation
Tekcapital helps clients profit from new, university-developed intellectual properties.
With our proprietary discovery search engine, linked to 4,000+ universities in 160 countries, coupled with expert scientific review, we provide a turn-key service to make it easy for clients to find and acquire the IP they need to create a competitive advantage.